NCT02612337已完成3 期
A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 3 Study of OTO-104 Given as a Single Intratympanic Injection in Subjects With Unilateral Meniere's Disease
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 166
- 试验地点
- 1
- 主要终点
- The Number of DVD at Week 12 (Defined as the 4-week [28 Days] Interval From Week 9 Through Week 12).
研究概览
简要总结
The purpose of this study is to evaluate the effectiveness of OTO-104 for the treatment of Meniere's disease.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
OTO-104
Experimental
12 mg dexamethasone
干预措施: OTO-104 (Drug)
Placebo
Placebo Comparator
干预措施: Placebo (Drug)
结局指标
主要结局
The Number of DVD at Week 12 (Defined as the 4-week [28 Days] Interval From Week 9 Through Week 12).
时间窗: Week 12 (3 months)
The number of DVDs at Week 12 (defined as the 4-week \[28 days\] interval from Week 9 through Week 12) was compared between OTO-104 and placebo. Week 12 = 12 weeks after dosing at the Baseline visit. Baseline occurred at the end of lead-in and no intervention was administered during lead-in.
次要结局
- Effect of Vertigo on Daily Activities - Number of Days Sick at Home or Bedridden at Week 12 (Month 3)(3 months)
- Otoscopic Examination - Tympanic Membrane Perforation at Week 12 (Month 3)(3 months)
- Audiometry - Shift in Air-Bone Gap at 500 Hz From Baseline to Week 12 (Month 3)(3 months)
- Audiometry - Shift in Air-Bone Gap at 1000 Hz From Baseline to Week 12 (Month 3)(Week 12 (Month 3))
- Audiometry - Shift in Air-Bone Gap at 2000 Hz From Baseline to Week 12 (Month 3)(Week 12 (Month 3))
研究者
研究点 (1)
Loading locations...
相似试验
终止
3 期
Study of OTO-104 in Subjects With Unilateral Meniere's DiseaseMeniere's DiseaseNCT02717442Otonomy, Inc.176
已完成
2 期
OTO-104 for the Treatment of Meniere's DiseaseMeniere's DiseaseNCT01412177Otonomy, Inc.154
已完成
3 期
Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's DiseaseMeniere DiseaseNCT03664674Otonomy, Inc.148
已完成
1 期
OTO-104 for Meniere's DiseaseMeniere's DiseaseNCT01084525Otonomy, Inc.44
已完成
2 期
A 1-Year Safety Study of OTO-104 in Subjects With Unilateral Meniere's Disease Located in United KingdomMeniere's DiseaseNCT02265393Otonomy, Inc.128